Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bard

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Investigation|July 1, 1993
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawalM Välimäki, J Kahri, K Laitinen, et al.
Journal of Lipid Research|October 1, 1995
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du MyocardeR Jemaa, F Fumeron, O Poirier, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1994
Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM StudyG Luc, J M Bard, D Arveiler, et al.
Metabolism: Clinical and Experimental|May 1, 1992
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein compositionJ M Bard, H J Parra, R Camare, et al.
Atherosclerosis|July 1, 1987
Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosisP Duriez, N Vu Dac, M Koffigan, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemiaJ M Bard, G Luc, P Douste-Blazy, et al.
Atherosclerosis|December 1, 1991
Lipoprotein particle analysis comparing simvastatin and fenofibrateJ M Bard, H J Parra, G Luc, et al.
The American Journal of Clinical Nutrition|July 1, 1991
n-3 polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young menF Fumeron, L Brigant, V Ollivier, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramineE Hagen, H Istad, L Ose, et al.
Clinical Genetics|October 1, 1991
Apolipoprotein B polymorphism and altered apolipoprotein B concentrations in Congolese blacksH J Parra, F Martin, F Monard, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Investigation|July 1, 1993
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawalM Välimäki, J Kahri, K Laitinen, et al.
Journal of Lipid Research|October 1, 1995
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du MyocardeR Jemaa, F Fumeron, O Poirier, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1994
Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM StudyG Luc, J M Bard, D Arveiler, et al.
Metabolism: Clinical and Experimental|May 1, 1992
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein compositionJ M Bard, H J Parra, R Camare, et al.
Atherosclerosis|July 1, 1987
Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosisP Duriez, N Vu Dac, M Koffigan, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemiaJ M Bard, G Luc, P Douste-Blazy, et al.
Atherosclerosis|December 1, 1991
Lipoprotein particle analysis comparing simvastatin and fenofibrateJ M Bard, H J Parra, G Luc, et al.
The American Journal of Clinical Nutrition|July 1, 1991
n-3 polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young menF Fumeron, L Brigant, V Ollivier, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramineE Hagen, H Istad, L Ose, et al.
Clinical Genetics|October 1, 1991
Apolipoprotein B polymorphism and altered apolipoprotein B concentrations in Congolese blacksH J Parra, F Martin, F Monard, et al.
Pageof 11